1stdibs.com, Inc. DIBS 深 沪
等待开盘 04-02 09:30:00 美东时间
5.51
+0.010
+0.18%
华盛通- 最 高5.64
- 今 开5.52
- 成交量 13.70万股
- 最 低 5.50
- 昨 收 5.50
- 总市值 2.00亿
- 52周最高 6.6247
- 市盈率 静 --
- 换手率 0.38%
- 52周最低 2.33
- 委 比 -10.61%
- 总股本 3638.20万
- 历史最高 35.46
- 量 比 0.77
- 振 幅 2.55%
- 历史最低 2.30
- 每 手 1
- 风险率 1.42%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 绩后暴跌超22%，MongoDB遭14家大行集团下调目标价；挪威邮轮、阿莎娜、Quantum Computing等也遭大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NRX Pharmaceuticals"买入"评级，目标价从40美元升至45美元；RBC Capital：维持NUVATION BIO"跑赢大市"评级，目标价从12美元升至13美元
03-04 10:22
Northland Capital Markets Upgrades 1stdibs.com to Outperform, Maintains Price Target to $7
Northland Capital Markets analyst Robert Brooks upgrades 1stdibs.com (NASDAQ:DIBS) from Market Perform to Outperform and maintains the price target from $7 to $7.
03-03 20:22
1stdibs.com shares are trading lower after the company reported worse-than-expected Q4 sales results. The company also issued Q1 sales guidance below estimates.
1stdibs.com shares are trading lower after the company reported worse-than-expe...
02-28 01:54
Earnings Breakdown: 1stdibs.com Q4
1stdibs.com (NASDAQ:DIBS) reported its Q4 earnings results on Friday, February ...
02-27 20:02
1stdibs.com Sees Q1 Sales $22.100M-$23.100M vs $23.120M Est
1stdibs.com (NASDAQ:DIBS) sees Q1 sales of $22.100 million-$23.100 million vs $23.120 million analyst estimate.
02-27 20:01
1stdibs.com Q4 EPS $(0.03) Beats $(0.04) Estimate, Sales $22.968M Miss $23.085M Estimate
1stdibs.com (NASDAQ:DIBS) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.04) by 25 percent. This is a 78.57 percent increase over losses of $(0.14) per share from the same
02-27 20:00
Earnings Scheduled For February 27, 2026
Companies Reporting Before The Bell • Escalade (NASDAQ:ESCA) is estimated to re...
02-27 19:11
Examining the Future: 1stdibs.com's Earnings Outlook
1stdibs.com (NASDAQ:DIBS) will release its quarterly earnings report on Friday,...
02-27 00:01
美股大行评级 | 潜在涨幅908.06%！Piper Sandler首予Palisade Bio(PALI)"超配"评级，目标价25美元
今日重点评级关注：Needham：维持Autolus Therapeutics"买入"评级，目标价从10美元升至11美元；BTIG：维持Praxis Precision Medicine"买入"评级，目标价从507美元升至843美元
2025-12-30 10:04
Northland Capital Markets Initiates Coverage On 1stdibs.com with Market Perform Rating, Announces Price Target of $7
Northland Capital Markets analyst Robert Brooks initiates coverage on 1stdibs.com (NASDAQ:DIBS) with a Market Perform rating and announces Price Target of $7.
2025-12-29 22:25
